Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay K Myo Min

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancers|May 16, 2023
Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and OpportunitiesKay K Myo Min, Charlie B Ffrench, Claire F Jessup, et al.
Cells|February 12, 2026
Unpacking the Tumor Protein D52-like Family: Roles in Intracellular Trafficking and Cancer ProgressionEmma L Dorward, Michael Ortiz, Claire M Weekley, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Oncoimmunology|March 17, 2022
Vasculogenic mimicry structures in melanoma support the recruitment of monocytesLih Y Tan, Michaelia P Cockshell, Eli Moore, et al.
Molecular Oncology|March 21, 2025
Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicryEmma J Thompson, Emma L Dorward, Kristyn Jurrius, et al.
Diabetes|February 9, 2017
Local Sphingosine Kinase 1 Activity Improves Islet TransplantationDarling Rojas-Canales, Daniella Penko, Kay K Myo Min, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Cell Death & Disease|October 30, 2022
Desmoglein-2 is important for islet function and β-cell survivalKay K Myo Min, Darling Rojas-Canales, Daniella Penko, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|May 16, 2023
Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and OpportunitiesKay K Myo Min, Charlie B Ffrench, Claire F Jessup, et al.
Cells|February 12, 2026
Unpacking the Tumor Protein D52-like Family: Roles in Intracellular Trafficking and Cancer ProgressionEmma L Dorward, Michael Ortiz, Claire M Weekley, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Oncoimmunology|March 17, 2022
Vasculogenic mimicry structures in melanoma support the recruitment of monocytesLih Y Tan, Michaelia P Cockshell, Eli Moore, et al.
Molecular Oncology|March 21, 2025
Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicryEmma J Thompson, Emma L Dorward, Kristyn Jurrius, et al.
Diabetes|February 9, 2017
Local Sphingosine Kinase 1 Activity Improves Islet TransplantationDarling Rojas-Canales, Daniella Penko, Kay K Myo Min, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Cell Death & Disease|October 30, 2022
Desmoglein-2 is important for islet function and β-cell survivalKay K Myo Min, Darling Rojas-Canales, Daniella Penko, et al.
Pageof 1